| A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events | N/A | Cleerly, Inc. | <1 mi |
| Study of WAL0921 in Patients With Glomerular Kidney Diseases | Phase 2 | Walden Biosciences | <1 mi |
| DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes | Phase 4 | Amsterdam UMC, location VUmc | <1 mi |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus | Phase 2 | Ascletis Pharma (China) Co., Limited | <1 mi |
| TrialNet Pathway to Prevention of T1D | — | University of South Florida | <1 mi |
| A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) | Phase 3 | Eli Lilly and Company | <1 mi |
| CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial | Phase 2 | Jason Sperry | <1 mi |
| Project Dulce for Arab Americans With Type 2 Diabetes | N/A | Scripps Whittier Diabetes Institute | <1 mi |
| VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) | Phase 3 | Viking Therapeutics, Inc. | <1 mi |
| Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis | Phase 2/3 | CSL Behring | <1 mi |
| A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy | Phase 2 | Boehringer Ingelheim | 5 mi |
| A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes | Phase 3 | Novo Nordisk A/S | 6 mi |
| Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes | Phase 3 | vTv Therapeutics | 6 mi |
| The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) | Phase 3 | Eli Lilly and Company | 7 mi |
| Pancreas Ultrasound Imaging in type1 Diabetes | — | University of Colorado, Denver | 8 mi |
| MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes | Phase 1 | Kalie Tommerdahl | 8 mi |
| Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D | — | University of Colorado, Denver | 8 mi |
| Rare and Atypical Diabetes Network | — | University of South Florida | 8 mi |
| A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease | Phase 2 | Novo Nordisk A/S | 8 mi |
| A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes | Phase 3 | Sanofi | 8 mi |
| GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes | N/A | Medtronic Diabetes | 8 mi |
| Colorado Community Engagement Alliance | — | University of Colorado, Denver | 8 mi |
| Type 1 Diabetes Extension Study | — | National Institute of Allergy and Infectious Diseases (NIAID) | 8 mi |
| Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes | — | University of Colorado, Denver | 8 mi |
| Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes | Phase 2 | University of Washington | 8 mi |
| A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes | Phase 1/2 | City of Hope Medical Center | 8 mi |
| INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes | Phase 2 | Mannkind Corporation | 8 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes | Phase 3 | Eli Lilly and Company | 8 mi |
| Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients | Phase 4 | University of Colorado, Denver | 8 mi |
| Type 1 Diabetes REst for Metabolic Health | N/A | University of Colorado, Denver | 8 mi |
| PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life | — | University of Colorado, Denver | 8 mi |
| Bionic Pancreas in CFRD | Phase 3 | Jaeb Center for Health Research | 8 mi |
| DISCOVERY of Risk Factors for Type 2 Diabetes in Youth | — | George Washington University | 8 mi |
| Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations | — | University of Colorado, Denver | 8 mi |
| AIDANET Pediatrics | N/A | Mark D. DeBoer, MD, MSc., MCR | 8 mi |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) | Phase 1/2 | COUR Pharmaceutical Development Company, Inc. | 8 mi |
| Renal Mechanism of SGLT2 Inhibition | Phase 2 | University of Colorado, Denver | 8 mi |
| TArgeting Type 1 Diabetes Using POLyamines (TADPOL) | Phase 2 | Emily K. Sims | 8 mi |
| Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes | Phase 3 | Kailera | 8 mi |
| Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes | N/A | University of Colorado, Denver | 8 mi |
| Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study) | — | Petter Bjornstad | 8 mi |
| Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes | Phase 2/3 | Jaeb Center for Health Research | 8 mi |
| T1D Pregnancy & Me | — | Jaeb Center for Health Research | 8 mi |
| Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes | Phase 4 | University of Colorado, Denver | 8 mi |
| Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation | N/A | VA Office of Research and Development | 8 mi |
| FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS) | Phase 2 | Sanofi | 8 mi |
| A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) | Phase 3 | Eli Lilly and Company | 8 mi |
| Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) | — | Jaeb Center for Health Research | 8 mi |
| Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery | N/A | University of Colorado, Denver | 8 mi |
| Breaking up Sedentary Time to Improve Glucose Control in a Population at Risk for Developing Type 2 Diabetes | Early 1 | University of Colorado, Denver | 8 mi |
| Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop Systems | N/A | University of Colorado, Denver | 8 mi |
| SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes | Phase 2 | SAb Biotherapeutics, Inc. | 8 mi |
| Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study) | — | University of Colorado, Denver | 8 mi |
| Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes | N/A | University of Colorado, Denver | 8 mi |
| GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance | Phase 2 | University of Pennsylvania | 8 mi |
| Registry for Stage 2 Type 1 Diabetes | — | Sanofi | 8 mi |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | Phase 3 | Boehringer Ingelheim | 8 mi |
| A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | Phase 2 | Children's Oncology Group | 8 mi |
| Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification | N/A | Chiara Fabris, PhD | 8 mi |
| Supporting VETerans With Kidney Disease Through Food As Medicine | N/A | VA Eastern Colorado Health Care System | 8 mi |
| Precision Administration of Anti-thymocyte Globulin With or Without Verapamil | Phase 2 | University of Florida | 8 mi |
| Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes | Phase 3 | University of Colorado, Denver | 8 mi |
| Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes | N/A | Colorado State University | 8 mi |
| North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) | — | Columbia University | 8 mi |
| Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease | Phase 3 | Alessandro Doria | 8 mi |
| Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes | Phase 4 | VA Office of Research and Development | 8 mi |
| Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes | N/A | Children's National Research Institute | 8 mi |